Rockefeller University Clinical Trials
Sponsors / Rockefeller University
80 ClinicalTrials.gov entries name Rockefeller University as the lead sponsor. The portfolio currently includes 2 recruiting studies, 1 active non-recruiting studies, and 64 completed studies. 12 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Cumulative planned enrollment across all listed trials is 4,451 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
80
Total Trials
2
Recruiting
1
Other Active
64
Completed
12
Terminated / Withdrawn
4,451
Total Enrollment
Termination reasons: Other42% · Recruitment33% · PI/or_Site25%
Recent Terminations
- NCT05272735 Stopped Sep 2025Hepatitis B"The yield of cells recovered from the lymph node fine needle aspirations was low limiting the ability to perform the planned immunologic assessments following HBV vaccination."
- Healthy"Inadequate enrollment"
- Disorders of Consciousness"Interrupted by Covid-19"
- Immune Deficiency"Target accrual not met"
- NCT01856647 Stopped Dec 2015Obesity"Low enrollment"
- Obesity"PI left institution"
- Healthy Volunteers"Due to mechanical issue with device"
- NCT01040650 Stopped Jan 2012Myopathy (Statin Associated)"Principal Investigator left institution"
- NCT01040039 Stopped Sep 2011HIV Infections"Investigator left Rockefeller University"
- Plaque Psoriasis"Unable to isolate sufficient cells from the skin biopsy to perform study experiments."
Active Trials (1 total)
- NCT02051114
- NCT06035549
- Preeclampsia EARLY_PHASE1NCT05709483